Uzbekistan Registration Holder Identity: Foreign Manufacturer Rights and the Local Legal Entity
Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
In Uzbekistan, a foreign manufacturer can retain the identity of the registration holder, but the registration certificate is obtained in the name of a legal entity registered in Uzbekistan. The TIN, legal address and contact details of that legal entity must appear in the instructions for use and on the labeling, and its name is published alongside the manufacturer in the state register. In other words, holding the qualification and being the submission subject are separated: the rights belong to the foreign manufacturer, while the certificate carrier is a local legal entity. Understanding this separation is the precondition for designing both the market access structure and the commercial agreements around it. It explains why the certificate can never simply be treated as the property of the local partner, and why the local partner can never treat the certificate as an asset it freely controls. Rights and carrier are deliberately split by the regulatory framework, and every contract, labeling layout and register entry should reflect that split consistently. Where the three public touchpoints — the instructions for use, the labeling and the state register — tell the same story, downstream customers, customs authorities and hospital procurement teams can verify the supply chain without friction. Where they diverge, every verification step becomes a potential point of delay or challenge. The separation also has a due diligence dimension. Before signing with any local entity, the manufacturer should confirm its registration status, tax standing and operational capacity, because once its TIN and legal address are printed on the labeling of every unit shipped, replacing it becomes a coordinated exercise across documents, registers and commercial agreements rather than a simple swap.
2. Legal basis
| Regulation | Number | Date | Provision |
|---|---|---|---|
| Cabinet Resolution approving the Regulation on the Procedure for State Registration of Medicines and Medical Devices and the Issuance of Registration Certificates | No. 738 | Adopted November 24, 2025, effective February 26, 2026 | Annex 2a: the applicant may be the developer, the manufacturer, the holder of the registration certificate, or a legal entity authorized by a power of attorney |
| Presidential Decree On Additional Measures to Regulate the Circulation of Medicines and Medical Devices | No. UP-137 | August 19, 2025 | Re-establishes the position of the authorized representative: the manufacturer is the registration holder, and the certificate is issued in the name of a legal entity registered in Uzbekistan |
| Cabinet Resolution approving the Regulation on the Procedure for State Registration of Medicines, Medical Use Products and Medical Equipment and the Issuance of Registration Certificates (superseded by Resolution No. 738) | No. 213 | March 23, 2018 (amended December 7, 2023) | Article 7: the registration certificate is the document confirming the fact of state registration and the authorization of the Ministry of Health for use in medical practice |
| Law of the Republic of Uzbekistan On Medicines and Pharmaceutical Activity | No. ZRU-399 (new edition) | January 4, 2016 | Article 14: information from the state register is published on the website of the Ministry of Health |
3. Expert insights
Insight 1: the applicant may be the developer, the manufacturer, the certificate holder, or an authorized legal entity — all four identities are lawful. Annex 2a of Resolution No. 738 lists four categories of entities that may file the application. This breadth gives companies room to design the access structure: the certificate can be held directly under the manufacturer arrangement, or carried by a local subsidiary or a third-party agency, depending on a combined assessment of tax treatment, channel strategy and risk management. There is no single correct answer; the choice should follow the commercial architecture rather than dictate it.
Insight 2: the local legal entity appears in three places, forming a visible rights structure. After August 2025, the TIN, legal address and contact details of the local legal entity must appear in the instructions for use and on the labeling, and its name is published alongside the manufacturer in the state register. These three public touchpoints jointly shape market perception of who is accountable for the product, and they determine who is examined by downstream customers and regulators. Keeping all three synchronized is therefore not a cosmetic exercise but a compliance requirement in its own right.
Insight 3: the representative cannot dispose of the certificate independently of the authority granted by the manufacturer. As the applicant and authorized representative, the local legal entity cannot dispose of the registration certificate on its own without the approval of the manufacturer granted through a power of attorney. This arrangement protects the rights of the foreign manufacturer, but it also means that once the authorization relationship breaks down, disposal of the certificate can reach a deadlock. Disposal clauses in the agreement therefore carry particular weight and should be negotiated before signature, not after a dispute arises.
Insight 4: the register entry is the public disclosure of the rights structure. Article 14 requires the state register information to be published on the website of the Ministry of Health. When importers and hospital procurement teams perform their checks, they look at the manufacturer and representative combination shown in the register. Any inconsistency between the register and the actual supply chain will be exposed at the verification stage, regardless of what the paper documents say.
4. Practical recommendations
- Define the combination of registration holder and applicant or representative at the access structure design stage, and record it in a tripartite agreement.
- Verify consistency across the instructions for use, the labeling and the register (TIN, legal address, contact details).
- State the disposal rules for the certificate in the authorization agreement, including renewal, variations, cancellation and dispute resolution.
- When changing the representative or holder, update the instructions for use, the labeling and the register simultaneously to avoid information gaps.
- Check the register entry together with importers and distributors to confirm it matches the actual supply chain.
5. Verification checklist
- □ The identity combination of registration holder and applicant or representative has been defined
- □ The instructions for use and labeling state the TIN, legal address and contact details of the local legal entity
- □ The manufacturer and representative information in the state register entry matches reality
- □ The authorization agreement states the disposal rules for the certificate (renewal, variation, cancellation, disputes)
- □ A synchronized update mechanism for changing the representative or holder has been established
- □ The register entry has been checked with importers and distributors
GRZAN supports manufacturers, importers and authorized representatives with medical device registration, holder structure design and market access in Uzbekistan. For assistance with your product portfolio, contact info@grzanglobal.com.
Regulatory information verified as of October 29, 2026.
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us